Pyrrolopyrazoles, potent kinase inhibitors

Details for Australian Patent Application No. 2005323797 (hide)

Owner Pfizer Inc.

Inventors Dong, Liming; Guo, Chuangxing; Li, Haitao; Marakovits, Joseph Timothy; Hong, Yufeng; Yang, Anle; Zhang, Junhu; Bouzida, Djamal

Agent Spruson & Ferguson

Pub. Number AU-B-2005323797

PCT Pub. Number WO2006/072831

Priority 60/733,770 04.11.05 US; 60/642,900 10.01.05 US

Filing date 28 December 2005

Wipo publication date 13 July 2006

Acceptance publication date 9 July 2009

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/072831 Priority application(s): WO2006/072831

9 July 2009 Application Accepted

  Published as AU-B-2005323797

5 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323805-Ultra low frequency moisture sensor

2005323794-Heteroaromatic quinoline compounds and their use as PDE10 inhibitors